Jules Haimovitz - 09 Mar 2026 Form 4 Insider Report for Armata Pharmaceuticals, Inc. (ARMP)

Role
Director
Signature
/s/ Jules Haimovitz
Issuer symbol
ARMP
Transactions as of
09 Mar 2026
Net transactions value
$0
Form type
4
Filing time
11 Mar 2026, 21:13:28 UTC
Previous filing
21 May 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Haimovitz Jules Director 5005 MCCONNELL AVENUE, LOS ANGELES /s/ Jules Haimovitz 11 Mar 2026 0001340855

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ARMP Stock Options (Right to Buy) Award +25,640 $0.000000* 25,640 09 Mar 2026 Common Stock 25,640 $11.61 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date.